Physician
Midway Specialty Care Center INC
Midway Specialty Care Center INC was paid $194K by Medicaid between Jan 2018 and Nov 2024, across 21 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 49% of everything it billed.
33Billing provider infoMIDWAY SPECIALTY CARE CENTER INC
FORT PIERCE, FL 34982
FORT PIERCE, FL 34982
33aNPI1376970814assigned 09/30/2013
33bProvider typeInfectious Disease Physician
28Total paid$194K
24GClaims12,268
24DCodes billed21
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Infectious Disease Physician providers in Florida
Rank by total paid#61 of 174
Median peer was paid$60K
This provider vs. median3.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 436 | $1K | |
| 2019 | 1,990 | $12K | |
| 2020 | 2,329 | $50K | |
| 2021 | 3,124 | $48K | |
| 2022 | 1,526 | $30K | |
| 2023 | 1,773 | $31K | |
| 2024incomplete | 1,090 | $22K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 49% | 4,887 | 3,738 | $95K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 1,730 | 1,286 | $26K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 12% | 511 | 412 | $23K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 12% | 562 | 445 | $23K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9.7% | 448 | 381 | $19K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.6% | 63 | 53 | $3K |
| 0002A | <1% | 175 | 149 | $2K | |
| 0001A | <1% | 187 | 150 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,794 | 2,124 | $554.15 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 130 | 104 | $498.84 |
| 99442 | <1% | 113 | 81 | $424.72 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 34 | 28 | $205.32 |
9 more codes
| 0003A | <1% | 26 | $40.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 35 | $11.00 |
| 91300 | <1% | 432 | $1.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 14 | $0.00 |
| 90688 | 0% | 19 | $0.00 | |
| 0011A | 0% | 19 | $0.00 | |
| 91301 | 0% | 54 | $0.00 | |
| 0012A | 0% | 20 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAMGOPAL, MOTI (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Associates in Infectious Diseases | Port St Lucie, FL | $520K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.